Abstract:This research assessed the anti-inflammatory and hepatoprotective properties of inosine and the associated mechanism. Inosine pretreatment significantly reduced the secretion of several inflammatory factors and serum alanine transaminase (ALT) and aspartate amino transferase (AST) levels in a dose-dependent manner compared with the lipopolysaccharide (LPS) group. In LPS-treated mice, inosine pretreatment significantly reduced the ALT and malondialdehyde (MDA) concentration and significantly elevated the antioxidant enzyme activity. Furthermore, inosine pretreatment significantly altered the relative abundance of the genera, Bifidobacterium, Lachnospiraceae UCG-006, and Muribaculum. Correlation analysis showed that Bifidobacterium and Lachnospiraceae UCG-006 were positively related to the cecal short-chain fatty acids but negatively related to the serum IL-6 and hepatic AST and ALT levels. Notably, inosine pretreatment significantly modulated the hepatic TLR4, MYD88, NF-κB, iNOS, COX2, AMPK, Nfr2, and IκB-α expression. These results suggested that inosine pretreatment alters the intestinal microbiota structure and improves LPS-induced acute liver damage and inflammation through modulating the TLR4/NF-κB signaling pathway.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jafc.1c01781?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jafc.1c01781</a>.Intestinal microflora in NC versus LPS groups compared at the genus level; primer sequences used in this study; and influence of inosine pre-treatment on cecal SCFAs in LPS-treated mice (<a class="ext-link" href="/doi/suppl/10.1021/acs.jafc.1c01781/suppl_file/jf1c01781_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Protective Effects of Microbiome-Derived Inosine on Lipopolysaccharide-Induced Acute Liver Damage and Inflammation in Mice via Mediating the TLR4/NF-κB Pathway